Literature DB >> 7492951

Inhibition of [3H]mebendazole binding to tubulin by structurally diverse microtubule inhibitors which interact at the colchicine binding site.

G J Russell1, E Lacey.   

Abstract

A rapid and convenient radioligand assay was used to characterise the interaction of several structurally diverse microtubule inhibitors with the colchicine binding domain of tubulin. Values determined for the inhibition of [3H]mebendazole binding to tubulin by colchicine, combretastatin A4, NSC 181928, NSC 321567, podophyllotoxin and tubulozole-C provided an independent measure of the relative potency of these compounds. This methodology has several advantages over the inhibition of [3H]colchicine binding as a technique for investigating the molecular mechanisms involved in determining tubulin-ligand interactions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492951

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  4 in total

1.  Quantitative analysis of the effect of tubulin isotype expression on sensitivity of cancer cell lines to a set of novel colchicine derivatives.

Authors:  Chih-Yuan Tseng; Jonathan Y Mane; Philip Winter; Lorelei Johnson; Torin Huzil; Elzbieta Izbicka; Richard F Luduena; Jack A Tuszynski
Journal:  Mol Cancer       Date:  2010-05-30       Impact factor: 27.401

2.  Treatment of breast and colon cancer cell lines with anti-helmintic benzimidazoles mebendazole or albendazole results in selective apoptotic cell death.

Authors:  Jakeb S S M Petersen; Sarah K Baird
Journal:  J Cancer Res Clin Oncol       Date:  2021-06-20       Impact factor: 4.553

3.  Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells.

Authors:  Zuzana Mrkvová; Stjepan Uldrijan; Antonio Pombinho; Petr Bartůněk; Iva Slaninová
Journal:  Molecules       Date:  2019-06-07       Impact factor: 4.411

4.  De novo identification of toxicants that cause irreparable damage to parasitic nematode intestinal cells.

Authors:  Douglas P Jasmer; Bruce A Rosa; Rahul Tyagi; Christina A Bulman; Brenda Beerntsen; Joseph F Urban; Judy Sakanari; Makedonka Mitreva
Journal:  PLoS Negl Trop Dis       Date:  2020-05-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.